163 related articles for article (PubMed ID: 15561901)
1. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
Bleck C; Wienbergen A; Rustenbeck I
Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
[TBL] [Abstract][Full Text] [Related]
2. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
3. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
Chan SL; Mourtada M; Morgan NG
Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
[TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous characteristics of imidazoline-induced insulin secretion.
Rustenbeck I; Leupolt L; Kowalewski R; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):235-42. PubMed ID: 10208311
[TBL] [Abstract][Full Text] [Related]
7. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
8. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
[TBL] [Abstract][Full Text] [Related]
9. Imidazolines and the pancreatic B-cell. Actions and binding sites.
Rustenbeck I; Köpp M; Ratzka P; Leupolt L; Hasselblatt A
Ann N Y Acad Sci; 1999 Jun; 881():229-40. PubMed ID: 10415921
[TBL] [Abstract][Full Text] [Related]
10. Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway.
Thams P; Anwar MR; Capito K
Eur J Endocrinol; 2005 Apr; 152(4):671-7. PubMed ID: 15817925
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
12. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
Høy M; Olsen HL; Andersen HS; Bokvist K; Buschard K; Hansen J; Jacobsen P; Petersen JS; Rorsman P; Gromada J
Eur J Pharmacol; 2003 Apr; 466(1-2):213-21. PubMed ID: 12679159
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
14. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery.
Zaitsev SV; Efanov AM; Efanova IB; Larsson O; Ostenson CG; Gold G; Berggren PO; Efendić S
Diabetes; 1996 Nov; 45(11):1610-8. PubMed ID: 8866568
[TBL] [Abstract][Full Text] [Related]
15. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
Mourtada M; Smith SA; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415
[TBL] [Abstract][Full Text] [Related]
16. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
Chan SL; Dunne MJ; Stillings MR; Morgan NG
Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
[TBL] [Abstract][Full Text] [Related]
17. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity.
Jeppesen PB; Gregersen S; Poulsen CR; Hermansen K
Metabolism; 2000 Feb; 49(2):208-14. PubMed ID: 10690946
[TBL] [Abstract][Full Text] [Related]
18. Glucose-regulated pulsatile insulin release from mouse islets via the K(ATP) channel-independent pathway.
Westerlund J; Ortsäter H; Palm F; Sundsten T; Bergsten P
Eur J Endocrinol; 2001 Jun; 144(6):667-75. PubMed ID: 11375802
[TBL] [Abstract][Full Text] [Related]
19. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
20. ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells.
Gromada J; Ma X; Høy M; Bokvist K; Salehi A; Berggren PO; Rorsman P
Diabetes; 2004 Dec; 53 Suppl 3():S181-9. PubMed ID: 15561909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
